These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17481801)

  • 21. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ; Al Salmani M; Al Hashami S; Al Mahrooqi S; Al Hinai S; Al Balushi H; Al Riyami N; Gowri V; Al Dughaishi T; Al Hosni S; Al-Khabori M; Al-Farsi K; Al Huneini M; Alkindi S
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monitoring and treatment of fetal maternal allo-immunization. Role of cordocentesis].
    Donner C; Lambermont M; Karioun A; Paquet V; Vermeylen D; Rodesch F
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(8):892-7. PubMed ID: 7706659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
    Lakhwani S; Machado P; Pecos P; Coloma M; Rebollo S; Raya JM
    Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
    Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal transfusion for red blood cell alloimmunization in pregnancy.
    Schumacher B; Moise KJ
    Obstet Gynecol; 1996 Jul; 88(1):137-50. PubMed ID: 8684747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroblastosis fetalis produced by anti-k.
    Bowman JM; Harman FA; Manning CR; Pollock JM
    Vox Sang; 1989; 56(3):187-9. PubMed ID: 2728396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kell antibodies in pregnancy].
    Rempen A; Schweppe KW
    Z Geburtshilfe Perinatol; 1983; 187(4):183-90. PubMed ID: 6684844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
    Collinet P; Subtil D; Puech F; Vaast P
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fetomaternal alloimmunization: role of cordocentesis].
    Donner C; Kadri R; Heymans O; Lambermont M; Gosselin F; Rodesch F
    Rev Med Brux; 1992 Apr; 13(4):124-8. PubMed ID: 1594825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe anemia due to Kell alloimmunization.
    Giannacopoulou CH; Relakis K; Kalmanti M
    Haematologia (Budap); 1997; 28(3):173-5. PubMed ID: 9283918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY; Porter AE; Queenan JT
    Am J Obstet Gynecol; 2001 Aug; 185(2):481-4. PubMed ID: 11518913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fetal hemolytic disease in a patient immunized by six antibodies: diagnosis and treatment].
    Tantalo V; Rossi E; Gianotti GA; Morotti R; Zuliani G; Buscaglia M; Galligani M
    Ann Ostet Ginecol Med Perinat; 1990; 111(5):321-5. PubMed ID: 2092607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Irregular blood group antibodies during pregnancy: screening is mandatory].
    Semmekrot BA; de Man AJ; Boekkooi PF; van Dijk BA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1449-52. PubMed ID: 10443258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E; Nikoloudi I; Kaminopetros P; Bolonaki I; Sifakis S; Kikidi K; Koumantakis E; Foundouli K
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Kell immunization--a case report].
    Tasić M; Milosević J; Stefanović M; Radović-Janosević D; Krstić M; Antić V
    Med Pregl; 2009; 62(7-8):369-72. PubMed ID: 19902791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-anti-D antibodies in red-cell alloimmunization.
    Moise KJ
    Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):75-81. PubMed ID: 10986438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of recombinant erythropoietin for the management of severe hemolytic disease of the newborn of a K0 phenotype mother.
    Manoura A; Korakaki E; Hatzidaki E; Saitakis E; Maraka S; Papamastoraki I; Matalliotakis E; Foundouli K; Giannakopoulou C
    Pediatr Hematol Oncol; 2007; 24(1):69-73. PubMed ID: 17130116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.